It is expected that on November 5, 2020, Mexico’s new Federal Law on Protection of Intellectual Property (LFPPI) will take effect. Pursuant to the LFPPI, the Mexican Institute of Industrial Property (IMPI) and the Federal Commission for the Protection against …
Filing a Divisional Application in Malaysia – Part 9
This is the ninth post in our 16-part series examining divisional practice in Argentina, Brazil, Canada, China, Europe, India, Indonesia, Malaysia, Mexico, Pakistan, Russia, Thailand, Saudi Arabia, Singapore, the United States, and Vietnam (in no particular order). Our first eight …
Read More "Filing a Divisional Application in Malaysia – Part 9"
Changes in Ukrainian Patent Law Strongly Favor Generic Manufacturers
On July 21, 2020, the Parliament of Ukraine introduced several major amendments to Ukrainian patent law. Although the amendments still need to be approved by the President in order to become effective, this is considered a mere formality and is …
Read More "Changes in Ukrainian Patent Law Strongly Favor Generic Manufacturers"
Zombie Patents? USPTO Issuing Notices of Abandonment in U.S. National Stage PCT Applications After Filing of an RCE where no Inventor Oath or Declaration or Substitute Statement has been Filed
Back on April 2, 2015, the U.S. Patent and Trademark Office (USPTO) published final rules for implementing the Geneva Act of the Hague Agreement Concerning the International Registration of Industrial Designs July 2, 1999 ( Final Rules ). Implementation of …
Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 3
Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 3 This 3-part series will provide an overview of the patentability of diagnostic inventions in the United States (U.S.), Europe and Canada. Part 1 examined the patentability …
Read More "Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 3"
Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 2
This 3-part series will provide an overview of the patentability of diagnostic inventions in the United States (U.S.), Europe and Canada. Part 1 examined the patentability of diagnostic inventions in the U.S. and can be found here . Part 2 …
Read More "Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 2"
Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 1
This 3-part series will provide a brief overview of the patentability of diagnostic inventions in the United States (U.S.), Europe and Canada. Part 1 will examine the patentability of diagnostic inventions in the U.S. United States As many readers are …
Read More "Patentability of Diagnostic Inventions in the United States, Europe and Canada – Part 1"
At last! Brazil is set to approve the Nagoya Protocol!
On July 8, 2020, the Brazilian Chamber of the State Representatives unanimously voted on the Bill of Legislative Decree # 324/20 to approve the Nagoya Protocol. As a result, the text was sent for consideration to the Senate and, once …
Read More "At last! Brazil is set to approve the Nagoya Protocol!"
Israeli Patent Office Clarifies Patent Term Extension (PTE) Requirements
Background Israel has a unique patent term extension (PTE) system. Patent term extension orders are granted only for patents that claim an active pharmaceutical ingredient (API) once a marketing authorization is issued for the first time by the Israeli Ministry …
Read More "Israeli Patent Office Clarifies Patent Term Extension (PTE) Requirements"
Ukraine Adopts a Bolar Exemption
On June 2, 2020, the Ukrainian Parliament passed a draft law introducing a legal exemption for patent infringement for actions relating to the development and submission of testing data to a Ukrainian regulator/authority for obtaining marketing authorization for medicinal products. …